Vytrus Biotech, S.A. (BME:VYT)
Spain · Delayed Price · Currency is EUR 8.40
-0.20 (-2.33%)
At close: Jan 16, 2026
Vytrus Biotech Market Cap
Vytrus Biotech has a market cap or net worth of €63.2 million as of January 16, 2026. Its market cap has increased by 288.04% in one year.
Market Cap
63.20M
Enterprise Value
61.34M
Revenue
8.09M
Ranking
n/a
PE Ratio
32.38
Stock Price
€8.40
Market Cap Chart
Since March 15, 2022, Vytrus Biotech's market cap has increased from 15.37M to 63.20M, an increase of 311.25%. That is a compound annual growth rate of 44.47%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 16, 2026 | 63.20M | -1.75% |
| Dec 31, 2025 | 64.33M | 294.97% |
| Dec 31, 2024 | 16.29M | 29.02% |
| Dec 29, 2023 | 12.62M | -46.26% |
| Dec 30, 2022 | 23.49M | 52.86% |
| Mar 15, 2022 | 15.37M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Grifols | 6.58B |
| Laboratorios Farmaceuticos Rovi | 3.58B |
| Almirall | 2.84B |
| Faes Farma | 1.59B |
| Pharma Mar | 1.39B |
| Clínica Baviera | 823.02M |
| Oryzon Genomics | 249.96M |
| Atrys Health | 232.18M |